aluates Reports

$ 0.0

Automative

Global Sustained-release Medicine Market Research Report 2026

Published Date: 2026-04-20

Report Code: QYRE-Auto-27L13848

Global Sustained release Medicine Market Research Report 2023

BUY CHAPTERS

Global Sustained-release Medicine Market Research Report 2026

Code: QYRE-Auto-27L13848

Report

2026-04-20

Pages:120

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

Novartis

Bayer

Johnson & Johnson

Takeda

Astrazeneca plc

AbbVie

Pfizer Inc

Collegium Pharmaceutical, Inc.

Endo Pharmaceuticals

Shanghai Shyndec Pharmaceutical

Zhuhai Rundu Pharmaceutical

China Res Double-Crane

Johnson & Johnson

Sustained-release Medicine Market Size

The global Sustained-release Medicine market was valued at US$ 41620 million in 2025 and is anticipated to reach US$ 65930 million by 2032, at a CAGR of 6.9% from 2026 to 2032.

Sustained-release Medicine Market

Sustained-release Medicine refer to preparations that can be continuously released for a long time after administration to achieve long-acting effects, and the drug release is mainly a first-order rate process. Controlled release preparations (controlled release preparations) refer to the preparations that can automatically release the drug at a predetermined speed within a predetermined time, so that the blood drug concentration can be kept constant within the effective concentration range for a long time.

Since there is no difference between sustained-release preparations and controlled-release preparations in the some countries, so, in this report, Extended release (ER), Sustained release (SR), Controlled release (CR) and Delayed release (D

The main global manufacturers of sustained-release drugs are Sanofi, Novartis, Bayer, Johnson & Johnson, Takeda, AstraZeneca, AbbVie, etc. The top seven manufacturers occupy a total market share of nearly 35%, of which the largest manufacturer is Sanofi, with a market share of 10.85%. Global sustained-release drug production regions are mainly located in Europe, the United States, China, etc., of which the top two regions occupy more than 65% of the market share. In terms of their product categories, original ground medicine have a higher market share of 63.96%, while generics have a lower share.

This report delivers a comprehensive overview of the global Sustained-release Medicine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sustained-release Medicine. The Sustained-release Medicine market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Sustained-release Medicine market comprehensively. Regional market sizes by Type, by Distribution Channel, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Sustained-release Medicine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Distribution Channel, and by region.

Market Segmentation

Scope of Sustained-release Medicine Market Report

Report Metric	Details
Report Name	Sustained-release Medicine Market
Accounted market size in 2025	US$ 41620 million
Forecasted market size in 2032	US$ 65930 million
CAGR	6.9%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Original Ground Medicine Generic Medicine
Segment by Distribution Channel	Hospital Drugstore Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, Novartis, Bayer, Johnson & Johnson, Takeda, AstraZeneca, AbbVie, Pfizer, Collegium Pharmaceutical, Inc, Endo Pharmaceuticals, Shanghai Shyndec Pharmaceutical, Zhuhai Rundu Pharmaceutical, China Res Double-Crane
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Distribution Channel, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Sustained-release Medicine companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Distribution Channel, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Sustained-release Medicine Market growing?

Ans: The Sustained-release Medicine Market witnessing a CAGR of 6.9% during the forecast period 2026-2032.

What is the Sustained-release Medicine Market size in 2032?

Ans: The Sustained-release Medicine Market size in 2032 will be US$ 65930 million.

What is the market share of major companies in Sustained-release Medicine Market?

Ans: The top seven manufacturers occupy a total market share of nearly 35%, of which the largest manufacturer is Sanofi, with a market share of 10.85%.

What is the Sustained-release Medicine Market share by type?

Ans: In terms of their product categories, original ground medicine have a higher market share of 63.96%, while generics have a lower share.

Who are the main players in the Sustained-release Medicine Market report?

Ans: The main players in the Sustained-release Medicine Market are Sanofi, Novartis, Bayer, Johnson & Johnson, Takeda, AstraZeneca, AbbVie, Pfizer, Collegium Pharmaceutical, Inc, Endo Pharmaceuticals, Shanghai Shyndec Pharmaceutical, Zhuhai Rundu Pharmaceutical, China Res Double-Crane

What are the Type segmentation covered in the Sustained-release Medicine Market report?

Ans: The Types covered in the Sustained-release Medicine Market report are Original Ground Medicine, Generic Medicine

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Sustained-release Medicine Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Original Ground Medicine

1.2.3 Generic Medicine

1.3 Market by Distribution Channel

1.3.1 Global Sustained-release Medicine Market Growth by Distribution Channel: 2021 vs 2025 vs 2032

1.3.2 Hospital

1.3.3 Drugstore

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Sustained-release Medicine Market Perspective (2021–2032)

2.2 Global Sustained-release Medicine Growth Trends by Region

2.2.1 Global Sustained-release Medicine Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Sustained-release Medicine Historic Market Size by Region (2021–2026)

2.2.3 Sustained-release Medicine Forecasted Market Size by Region (2027–2032)

2.3 Sustained-release Medicine Market Dynamics

2.3.1 Sustained-release Medicine Industry Trends

2.3.2 Sustained-release Medicine Market Drivers

2.3.3 Sustained-release Medicine Market Challenges

2.3.4 Sustained-release Medicine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Sustained-release Medicine Players by Revenue

3.1.1 Global Top Sustained-release Medicine Players by Revenue (2021–2026)

3.1.2 Global Sustained-release Medicine Revenue Market Share by Players (2021–2026)

3.2 Global Top Sustained-release Medicine Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Sustained-release Medicine Revenue

3.4 Global Sustained-release Medicine Market Concentration Ratio

3.4.1 Global Sustained-release Medicine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Sustained-release Medicine Revenue in 2025

3.5 Global Key Players of Sustained-release Medicine Head Offices and Areas Served

3.6 Global Key Players of Sustained-release Medicine, Products and Applications

3.7 Global Key Players of Sustained-release Medicine, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Sustained-release Medicine Breakdown Data by Type

4.1 Global Sustained-release Medicine Historic Market Size by Type (2021–2026)

4.2 Global Sustained-release Medicine Forecasted Market Size by Type (2027–2032)

5 Sustained-release Medicine Breakdown Data by Distribution Channel

5.1 Global Sustained-release Medicine Historic Market Size by Distribution Channel (2021–2026)

5.2 Global Sustained-release Medicine Forecasted Market Size by Distribution Channel (2027–2032)

6 North America

6.1 North America Sustained-release Medicine Market Size (2021–2032)

6.2 North America Sustained-release Medicine Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Sustained-release Medicine Market Size by Country (2021–2026)

6.4 North America Sustained-release Medicine Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Sustained-release Medicine Market Size (2021–2032)

7.2 Europe Sustained-release Medicine Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Sustained-release Medicine Market Size by Country (2021–2026)

7.4 Europe Sustained-release Medicine Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Sustained-release Medicine Market Size (2021–2032)

8.2 Asia-Pacific Sustained-release Medicine Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Sustained-release Medicine Market Size by Region (2021–2026)

8.4 Asia-Pacific Sustained-release Medicine Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Sustained-release Medicine Market Size (2021–2032)

9.2 Latin America Sustained-release Medicine Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Sustained-release Medicine Market Size by Country (2021–2026)

9.4 Latin America Sustained-release Medicine Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Sustained-release Medicine Market Size (2021–2032)

10.2 Middle East & Africa Sustained-release Medicine Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Sustained-release Medicine Market Size by Country (2021–2026)

10.4 Middle East & Africa Sustained-release Medicine Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Sustained-release Medicine Introduction

11.1.4 Sanofi Revenue in Sustained-release Medicine Business (2021–2026)

11.1.5 Sanofi Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Sustained-release Medicine Introduction

11.2.4 Novartis Revenue in Sustained-release Medicine Business (2021–2026)

11.2.5 Novartis Recent Development

11.3 Bayer

11.3.1 Bayer Company Details

11.3.2 Bayer Business Overview

11.3.3 Bayer Sustained-release Medicine Introduction

11.3.4 Bayer Revenue in Sustained-release Medicine Business (2021–2026)

11.3.5 Bayer Recent Development

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Details

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson Sustained-release Medicine Introduction

11.4.4 Johnson & Johnson Revenue in Sustained-release Medicine Business (2021–2026)

11.4.5 Johnson & Johnson Recent Development

11.5 Takeda

11.5.1 Takeda Company Details

11.5.2 Takeda Business Overview

11.5.3 Takeda Sustained-release Medicine Introduction

11.5.4 Takeda Revenue in Sustained-release Medicine Business (2021–2026)

11.5.5 Takeda Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Details

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Sustained-release Medicine Introduction

11.6.4 AstraZeneca Revenue in Sustained-release Medicine Business (2021–2026)

11.6.5 AstraZeneca Recent Development

11.7 AbbVie

11.7.1 AbbVie Company Details

11.7.2 AbbVie Business Overview

11.7.3 AbbVie Sustained-release Medicine Introduction

11.7.4 AbbVie Revenue in Sustained-release Medicine Business (2021–2026)

11.7.5 AbbVie Recent Development

11.8 Pfizer

11.8.1 Pfizer Company Details

11.8.2 Pfizer Business Overview

11.8.3 Pfizer Sustained-release Medicine Introduction

11.8.4 Pfizer Revenue in Sustained-release Medicine Business (2021–2026)

11.8.5 Pfizer Recent Development

11.9 Collegium Pharmaceutical, Inc

11.9.1 Collegium Pharmaceutical, Inc Company Details

11.9.2 Collegium Pharmaceutical, Inc Business Overview

11.9.3 Collegium Pharmaceutical, Inc Sustained-release Medicine Introduction

11.9.4 Collegium Pharmaceutical, Inc Revenue in Sustained-release Medicine Business (2021–2026)

11.9.5 Collegium Pharmaceutical, Inc Recent Development

11.10 Endo Pharmaceuticals

11.10.1 Endo Pharmaceuticals Company Details

11.10.2 Endo Pharmaceuticals Business Overview

11.10.3 Endo Pharmaceuticals Sustained-release Medicine Introduction

11.10.4 Endo Pharmaceuticals Revenue in Sustained-release Medicine Business (2021–2026)

11.10.5 Endo Pharmaceuticals Recent Development

11.11 Shanghai Shyndec Pharmaceutical

11.11.1 Shanghai Shyndec Pharmaceutical Company Details

11.11.2 Shanghai Shyndec Pharmaceutical Business Overview

11.11.3 Shanghai Shyndec Pharmaceutical Sustained-release Medicine Introduction

11.11.4 Shanghai Shyndec Pharmaceutical Revenue in Sustained-release Medicine Business (2021–2026)

11.11.5 Shanghai Shyndec Pharmaceutical Recent Development

11.12 Zhuhai Rundu Pharmaceutical

11.12.1 Zhuhai Rundu Pharmaceutical Company Details

11.12.2 Zhuhai Rundu Pharmaceutical Business Overview

11.12.3 Zhuhai Rundu Pharmaceutical Sustained-release Medicine Introduction

11.12.4 Zhuhai Rundu Pharmaceutical Revenue in Sustained-release Medicine Business (2021–2026)

11.12.5 Zhuhai Rundu Pharmaceutical Recent Development

11.13 China Res Double-Crane

11.13.1 China Res Double-Crane Company Details

11.13.2 China Res Double-Crane Business Overview

11.13.3 China Res Double-Crane Sustained-release Medicine Introduction

11.13.4 China Res Double-Crane Revenue in Sustained-release Medicine Business (2021–2026)

11.13.5 China Res Double-Crane Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sanofi

Novartis

Bayer

Johnson & Johnson

Takeda

Astrazeneca plc

AbbVie

Pfizer Inc

Collegium Pharmaceutical, Inc.

Endo Pharmaceuticals

Shanghai Shyndec Pharmaceutical

Zhuhai Rundu Pharmaceutical

China Res Double-Crane

Johnson & Johnson

List of Tables

Table 1. Global Sustained-release Medicine Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Original Ground Medicine

Table 3. Key Players of Generic Medicine

Table 4. Global Sustained-release Medicine Market Size Growth by Distribution Channel (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Sustained-release Medicine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Sustained-release Medicine Market Size by Region (US$ Million), 2021–2026

Table 7. Global Sustained-release Medicine Market Share by Region (2021–2026)

Table 8. Global Sustained-release Medicine Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Sustained-release Medicine Market Share by Region (2027–2032)

Table 10. Sustained-release Medicine Market Trends

Table 11. Sustained-release Medicine Market Drivers

Table 12. Sustained-release Medicine Market Challenges

Table 13. Sustained-release Medicine Market Restraints

Table 14. Global Sustained-release Medicine Revenue by Players (US$ Million), 2021–2026

Table 15. Global Sustained-release Medicine Market Share by Players (2021–2026)

Table 16. Global Top Sustained-release Medicine Players by Tier (Tier 1, Tier 2, and Tier 3), based on Sustained-release Medicine Revenue, 2025

Table 17. Ranking of Global Top Sustained-release Medicine Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Sustained-release Medicine Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Sustained-release Medicine, Headquarters and Area Served

Table 20. Global Key Players of Sustained-release Medicine, Products and Applications

Table 21. Global Key Players of Sustained-release Medicine, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Sustained-release Medicine Market Size by Type (US$ Million), 2021–2026

Table 24. Global Sustained-release Medicine Revenue Market Share by Type (2021–2026)

Table 25. Global Sustained-release Medicine Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Sustained-release Medicine Revenue Market Share by Type (2027–2032)

Table 27. Global Sustained-release Medicine Market Size by Distribution Channel (US$ Million), 2021–2026

Table 28. Global Sustained-release Medicine Revenue Market Share by Distribution Channel (2021–2026)

Table 29. Global Sustained-release Medicine Forecasted Market Size by Distribution Channel (US$ Million), 2027–2032

Table 30. Global Sustained-release Medicine Revenue Market Share by Distribution Channel (2027–2032)

Table 31. North America Sustained-release Medicine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Sustained-release Medicine Market Size by Country (US$ Million), 2021–2026

Table 33. North America Sustained-release Medicine Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Sustained-release Medicine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Sustained-release Medicine Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Sustained-release Medicine Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Sustained-release Medicine Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Sustained-release Medicine Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Sustained-release Medicine Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Sustained-release Medicine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Sustained-release Medicine Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Sustained-release Medicine Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Sustained-release Medicine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Sustained-release Medicine Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Sustained-release Medicine Market Size by Country (US$ Million), 2027–2032

Table 46. Sanofi Company Details

Table 47. Sanofi Business Overview

Table 48. Sanofi Sustained-release Medicine Product

Table 49. Sanofi Revenue in Sustained-release Medicine Business (US$ Million), 2021–2026

Table 50. Sanofi Recent Development

Table 51. Novartis Company Details

Table 52. Novartis Business Overview

Table 53. Novartis Sustained-release Medicine Product

Table 54. Novartis Revenue in Sustained-release Medicine Business (US$ Million), 2021–2026

Table 55. Novartis Recent Development

Table 56. Bayer Company Details

Table 57. Bayer Business Overview

Table 58. Bayer Sustained-release Medicine Product

Table 59. Bayer Revenue in Sustained-release Medicine Business (US$ Million), 2021–2026

Table 60. Bayer Recent Development

Table 61. Johnson & Johnson Company Details

Table 62. Johnson & Johnson Business Overview

Table 63. Johnson & Johnson Sustained-release Medicine Product

Table 64. Johnson & Johnson Revenue in Sustained-release Medicine Business (US$ Million), 2021–2026

Table 65. Johnson & Johnson Recent Development

Table 66. Takeda Company Details

Table 67. Takeda Business Overview

Table 68. Takeda Sustained-release Medicine Product

Table 69. Takeda Revenue in Sustained-release Medicine Business (US$ Million), 2021–2026

Table 70. Takeda Recent Development

Table 71. AstraZeneca Company Details

Table 72. AstraZeneca Business Overview

Table 73. AstraZeneca Sustained-release Medicine Product

Table 74. AstraZeneca Revenue in Sustained-release Medicine Business (US$ Million), 2021–2026

Table 75. AstraZeneca Recent Development

Table 76. AbbVie Company Details

Table 77. AbbVie Business Overview

Table 78. AbbVie Sustained-release Medicine Product

Table 79. AbbVie Revenue in Sustained-release Medicine Business (US$ Million), 2021–2026

Table 80. AbbVie Recent Development

Table 81. Pfizer Company Details

Table 82. Pfizer Business Overview

Table 83. Pfizer Sustained-release Medicine Product

Table 84. Pfizer Revenue in Sustained-release Medicine Business (US$ Million), 2021–2026

Table 85. Pfizer Recent Development

Table 86. Collegium Pharmaceutical, Inc Company Details

Table 87. Collegium Pharmaceutical, Inc Business Overview

Table 88. Collegium Pharmaceutical, Inc Sustained-release Medicine Product

Table 89. Collegium Pharmaceutical, Inc Revenue in Sustained-release Medicine Business (US$ Million), 2021–2026

Table 90. Collegium Pharmaceutical, Inc Recent Development

Table 91. Endo Pharmaceuticals Company Details

Table 92. Endo Pharmaceuticals Business Overview

Table 93. Endo Pharmaceuticals Sustained-release Medicine Product

Table 94. Endo Pharmaceuticals Revenue in Sustained-release Medicine Business (US$ Million), 2021–2026

Table 95. Endo Pharmaceuticals Recent Development

Table 96. Shanghai Shyndec Pharmaceutical Company Details

Table 97. Shanghai Shyndec Pharmaceutical Business Overview

Table 98. Shanghai Shyndec Pharmaceutical Sustained-release Medicine Product

Table 99. Shanghai Shyndec Pharmaceutical Revenue in Sustained-release Medicine Business (US$ Million), 2021–2026

Table 100. Shanghai Shyndec Pharmaceutical Recent Development

Table 101. Zhuhai Rundu Pharmaceutical Company Details

Table 102. Zhuhai Rundu Pharmaceutical Business Overview

Table 103. Zhuhai Rundu Pharmaceutical Sustained-release Medicine Product

Table 104. Zhuhai Rundu Pharmaceutical Revenue in Sustained-release Medicine Business (US$ Million), 2021–2026

Table 105. Zhuhai Rundu Pharmaceutical Recent Development

Table 106. China Res Double-Crane Company Details

Table 107. China Res Double-Crane Business Overview

Table 108. China Res Double-Crane Sustained-release Medicine Product

Table 109. China Res Double-Crane Revenue in Sustained-release Medicine Business (US$ Million), 2021–2026

Table 110. China Res Double-Crane Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

Table 114. Authors List of This Report

List of Figures

Figure 1. Sustained-release Medicine Picture

Figure 2. Global Sustained-release Medicine Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Sustained-release Medicine Market Share by Type: 2025 vs 2032

Figure 4. Original Ground Medicine Features

Figure 5. Generic Medicine Features

Figure 6. Global Sustained-release Medicine Market Size by Distribution Channel (US$ Million), 2021–2032

Figure 7. Global Sustained-release Medicine Market Share by Distribution Channel: 2025 vs 2032

Figure 8. Hospital Case Studies

Figure 9. Drugstore Case Studies

Figure 10. Other Case Studies

Figure 11. Sustained-release Medicine Report Years Considered

Figure 12. Global Sustained-release Medicine Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 13. Global Sustained-release Medicine Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Sustained-release Medicine Market Share by Region: 2025 vs 2032

Figure 15. Global Sustained-release Medicine Market Share by Players in 2025

Figure 16. Global Sustained-release Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Sustained-release Medicine Revenue in 2025

Figure 18. North America Sustained-release Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 19. North America Sustained-release Medicine Market Share by Country (2021–2032)

Figure 20. United States Sustained-release Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Canada Sustained-release Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Sustained-release Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Sustained-release Medicine Market Share by Country (2021–2032)

Figure 24. Germany Sustained-release Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. France Sustained-release Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. U.K. Sustained-release Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Italy Sustained-release Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Russia Sustained-release Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Ireland Sustained-release Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Sustained-release Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Sustained-release Medicine Market Share by Region (2021–2032)

Figure 32. China Sustained-release Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Japan Sustained-release Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. South Korea Sustained-release Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Southeast Asia Sustained-release Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. India Sustained-release Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Australia & New Zealand Sustained-release Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Sustained-release Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Sustained-release Medicine Market Share by Country (2021–2032)

Figure 40. Mexico Sustained-release Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Brazil Sustained-release Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Sustained-release Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Sustained-release Medicine Market Share by Country (2021–2032)

Figure 44. Israel Sustained-release Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Saudi Arabia Sustained-release Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. UAE Sustained-release Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Sanofi Revenue Growth Rate in Sustained-release Medicine Business (2021–2026)

Figure 48. Novartis Revenue Growth Rate in Sustained-release Medicine Business (2021–2026)

Figure 49. Bayer Revenue Growth Rate in Sustained-release Medicine Business (2021–2026)

Figure 50. Johnson & Johnson Revenue Growth Rate in Sustained-release Medicine Business (2021–2026)

Figure 51. Takeda Revenue Growth Rate in Sustained-release Medicine Business (2021–2026)

Figure 52. AstraZeneca Revenue Growth Rate in Sustained-release Medicine Business (2021–2026)

Figure 53. AbbVie Revenue Growth Rate in Sustained-release Medicine Business (2021–2026)

Figure 54. Pfizer Revenue Growth Rate in Sustained-release Medicine Business (2021–2026)

Figure 55. Collegium Pharmaceutical, Inc Revenue Growth Rate in Sustained-release Medicine Business (2021–2026)

Figure 56. Endo Pharmaceuticals Revenue Growth Rate in Sustained-release Medicine Business (2021–2026)

Figure 57. Shanghai Shyndec Pharmaceutical Revenue Growth Rate in Sustained-release Medicine Business (2021–2026)

Figure 58. Zhuhai Rundu Pharmaceutical Revenue Growth Rate in Sustained-release Medicine Business (2021–2026)

Figure 59. China Res Double-Crane Revenue Growth Rate in Sustained-release Medicine Business (2021–2026)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Extended release Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sustained Release Excipients Market Insights Forecast to 2030

Global Sustained and Controlled Release Formulations Market Research Report 2025

Global Oral Sustained and Controlled Release Formulations Market Research Report 2025

Global Liquid Formulations Drug Delivery Market Research Report 2025

Pharma Grade Hydroxypropyl Methylcellulose Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Metformin Hydrochloride Sustained release Tablets Market Research Report 2024

Continuous Manufacturing in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Carbidopa and Levodopa Sustained release Tablets Market Research Report 2024

Global Sustained Release Coatings Market Insights Forecast to 2030

Global Long acting Weight Loss Drugs Market Research Report 2024

Sustained Release Film Coating Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sustained Release Drug Delivery Systems Market Research Report 2024

Global In Vitro Drug Release Testing Market Research Report 2024

Global Oral Controlled Release Drug Delivery Technology Market Research Report 2024

Global Slow release Microspheres for Injection Market Research Report 2024

Global Lyophilized Drugs Market Research Report 2024

Global Parenteral Packaging Market Research Report 2024

Global Smart Drug releasing Patches Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions